Last 12 months
Inside the activity.
0 purchase rows · 131 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 8 |
| Dec 2025 | 0 | 8 |
| Jan 2026 | 0 | 5 |
| Feb 2026 | 0 | 5 |
| Mar 2026 | 0 | 32 |
| Apr 2026 | 0 | 11 |
| May 2026 | 0 | 14 |
| Jun 2026 | 0 | 16 |
| Jul 2026 | 0 | 8 |
| Aug 2026 | 0 | 12 |
| Sep 2026 | 0 | 6 |
| Oct 2026 | 0 | 6 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 01, 2026 Filed Jul 6, 2026 21:11 UTC |
Reardon AndrewCLO & Secretary
|
Exercise / conversionCommon Stock | 5,000 | $52.27 | $261,350.00 |
DisclosureSEC source: 0002001011-26-000108 · edgardoc.xml · nonDerivative · entry 2 Reardon Andrew · CIK 0001950232 · CLO & Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 46,514 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: The transactions reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on November 24, 2025, in accordance with Rule 10b5-1. Read SEC document |
| June 30, 2026 Filed Jul 6, 2026 21:11 UTC |
Reardon AndrewCLO & Secretary
|
OtherCommon Stock | 132 | $160.71 | $21,213.65 |
DisclosureSEC source: 0002001011-26-000108 · edgardoc.xml · nonDerivative · entry 1 Reardon Andrew · CIK 0001950232 · CLO & Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 41,514 F1 · kind: These shares were acquired under the Ligand Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| June 30, 2026 Filed Jul 6, 2026 21:11 UTC |
Espinoza OctavioChief Financial Officer
|
OtherCommon Stock | 17 | $160.71 | $2,732.06 |
DisclosureSEC source: 0002001011-26-000107 · edgardoc.xml · nonDerivative · entry 1 Espinoza Octavio · CIK 0001905248 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,696 F1 · kind: These shares were acquired under the Ligand Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| June 30, 2026 Filed Jul 6, 2026 21:10 UTC |
Davis Todd CDirector · Chief Executive Officer
|
OtherCommon Stock | 132 | $160.71 | $21,213.65 |
DisclosureSEC source: 0002001011-26-000106 · edgardoc.xml · nonDerivative · entry 1 Davis Todd C · CIK 0001392029 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 199,513 F1 · kind: These shares were acquired under the Ligand Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| June 16, 2026 Filed Jun 18, 2026 12:37 UTC |
Sabba Stephen LDirector
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 2,145 | $0.00 Strike: $66.13 | $0.00 |
DisclosureSEC source: 0001104659-26-075456 · tm2618247-1_4seq1.xml · derivative · entry 3 Sabba Stephen L · CIK 0001442372 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,145 shares Expires 2027-05-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: These securities, as represented in Column 5, were acquired by a grant of 2,456 shares approved by the Board of Directors of the Company at the 2017 Meeting, as previously reported on the Reporting Person's Form 4, dated 30 May 2017. That grant vested in full on the first anniversary of the grant date or immediately (x) upon a change in control or a hostile takeover of the Company or (y) the death or permanent disability of the grantee if still serving at that time. The original grant was adjusted to 2,145 shares and the exercise price adjusted to $66.13 pursuant to the OmniAb Inc. separation from the Company. F2 · derivative.exercise_date: These securities, as represented in Column 5, were acquired by a grant of 2,456 shares approved by the Board of Directors of the Company at the 2017 Meeting, as previously reported on the Reporting Person's Form 4, dated 30 May 2017. That grant vested in full on the first anniversary of the grant date or immediately (x) upon a change in control or a hostile takeover of the Company or (y) the death or permanent disability of the grantee if still serving at that time. The original grant was adjusted to 2,145 shares and the exercise price adjusted to $66.13 pursuant to the OmniAb Inc. separation from the Company. Read SEC document |
| June 16, 2026 Filed Jun 18, 2026 12:37 UTC |
Sabba Stephen LDirector
|
SaleCommon Stock | 2,145 | $254.00 | $544,830.00 |
DisclosureSEC source: 0001104659-26-075456 · tm2618247-1_4seq1.xml · nonDerivative · entry 2 Sabba Stephen L · CIK 0001442372 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,629 F1 · security: These securities, as represented in Column 5, include the grant of 836 restricted shares approved by the Board of Directors of the Company at the 2026 Meeting held 5 June 2026, which shares were previously reported on a Form 4 for this Reporting Person dated 9 June 2026. Read SEC document |
| June 16, 2026 Filed Jun 18, 2026 12:37 UTC |
Sabba Stephen LDirector
|
Exercise / conversionCommon Stock | 2,145 | $66.13 | $141,848.85 |
DisclosureSEC source: 0001104659-26-075456 · tm2618247-1_4seq1.xml · nonDerivative · entry 1 Sabba Stephen L · CIK 0001442372 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,774 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities, as represented in Column 5, include the grant of 836 restricted shares approved by the Board of Directors of the Company at the 2026 Meeting held 5 June 2026, which shares were previously reported on a Form 4 for this Reporting Person dated 9 June 2026. Read SEC document |
| June 12, 2026 Filed Jun 16, 2026 01:06 UTC |
Haas JasonDirector
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 1,000 | $0.00 Strike: $51.56 | $0.00 |
DisclosureSEC source: 0002001011-26-000104 · edgardoc.xml · derivative · entry 6 Haas Jason · CIK 0001883821 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,138 Underlying: Common Stock · 1,000 shares Expires 2032-06-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This Option was previously reported as a Grant of 5,907 shares on June 29, 2022, at an exercise price of $88.48 per share, which becomes exercisable in three successive annual installments upon completion of each calendar year of service beginning on the grant date, but was adjusted pursuant to the OmniAb Inc. separation from the issuer. Read SEC document |
| June 12, 2026 Filed Jun 16, 2026 01:06 UTC |
Haas JasonDirector
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 3,000 | $0.00 Strike: $51.56 | $0.00 |
DisclosureSEC source: 0002001011-26-000104 · edgardoc.xml · derivative · entry 5 Haas Jason · CIK 0001883821 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,138 Underlying: Common Stock · 3,000 shares Expires 2032-06-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This Option was previously reported as a Grant of 5,907 shares on June 29, 2022, at an exercise price of $88.48 per share, which becomes exercisable in three successive annual installments upon completion of each calendar year of service beginning on the grant date, but was adjusted pursuant to the OmniAb Inc. separation from the issuer. Read SEC document |
| June 12, 2026 Filed Jun 16, 2026 01:06 UTC |
Haas JasonDirector
|
SaleCommon Stock | 3,461 | $256.08 | $886,286.30 |
DisclosureSEC source: 0002001011-26-000104 · edgardoc.xml · nonDerivative · entry 4 Haas Jason · CIK 0001883821 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,981 F2 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $256.0000 to $256.5100. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 12, 2026 Filed Jun 16, 2026 01:06 UTC |
Haas JasonDirector
|
SaleCommon Stock | 3,000 | $255.01 | $765,033.90 |
DisclosureSEC source: 0002001011-26-000104 · edgardoc.xml · nonDerivative · entry 3 Haas Jason · CIK 0001883821 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,442 F1 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $255.0000 to $255.2900. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 12, 2026 Filed Jun 16, 2026 01:06 UTC |
Haas JasonDirector
|
Exercise / conversionCommon Stock | 1,000 | $51.56 | $51,560.00 |
DisclosureSEC source: 0002001011-26-000104 · edgardoc.xml · nonDerivative · entry 2 Haas Jason · CIK 0001883821 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,442 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 12, 2026 Filed Jun 16, 2026 01:06 UTC |
Haas JasonDirector
|
Exercise / conversionCommon Stock | 3,000 | $51.56 | $154,680.00 |
DisclosureSEC source: 0002001011-26-000104 · edgardoc.xml · nonDerivative · entry 1 Haas Jason · CIK 0001883821 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,442 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 11, 2026 Filed Jun 12, 2026 21:27 UTC |
Aryeh JasonDirector
|
SaleCommon Stock | 4,500 | $250.00 | $1,125,000.00 |
DisclosureSEC source: 0002001011-26-000103 · edgardoc.xml · nonDerivative · entry 3 Aryeh Jason · CIK 0001376960 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 102,580 Read SEC document |
| June 10, 2026 Filed Jun 12, 2026 21:27 UTC |
Aryeh JasonDirector
|
SaleCommon Stock | 500 | $250.00 | $125,000.00 |
DisclosureSEC source: 0002001011-26-000103 · edgardoc.xml · nonDerivative · entry 2 Aryeh Jason · CIK 0001376960 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 107,080 Read SEC document |
| June 10, 2026 Filed Jun 12, 2026 21:26 UTC |
LAMATTINA JOHN LDirector
|
SaleCommon Stock | 3,405 | $251.62 | $856,751.80 |
DisclosureSEC source: 0002001011-26-000102 · edgardoc.xml · nonDerivative · entry 4 LAMATTINA JOHN L · CIK 0001216074 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,969 F4 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $250.9100 to $251.8950. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 10, 2026 Filed Jun 12, 2026 21:26 UTC |
LAMATTINA JOHN LDirector
|
SaleCommon Stock | 697 | $249.53 | $173,924.22 |
DisclosureSEC source: 0002001011-26-000102 · edgardoc.xml · nonDerivative · entry 3 LAMATTINA JOHN L · CIK 0001216074 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,374 F3 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $249.3400 to $250.2700. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 10, 2026 Filed Jun 12, 2026 21:26 UTC |
LAMATTINA JOHN LDirector
|
SaleCommon Stock | 232 | $248.11 | $57,561.78 |
DisclosureSEC source: 0002001011-26-000102 · edgardoc.xml · nonDerivative · entry 2 LAMATTINA JOHN L · CIK 0001216074 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,071 F2 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $247.9400 to $248.3350. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 10, 2026 Filed Jun 12, 2026 21:26 UTC |
LAMATTINA JOHN LDirector
|
SaleCommon Stock | 257 | $247.22 | $63,536.49 |
DisclosureSEC source: 0002001011-26-000102 · edgardoc.xml · nonDerivative · entry 1 LAMATTINA JOHN L · CIK 0001216074 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,303 F1 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $246.6300 to $247.6100. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 05, 2026 Filed Jun 9, 2026 23:42 UTC |
Zimmermann MartineDirector
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 2,938 | $0.00 Strike: $237.00 | $0.00 |
DisclosureSEC source: 0002001011-26-000101 · edgardoc.xml · derivative · entry 3 Zimmermann Martine · CIK 0001994049 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,938 Underlying: Common Stock · 2,938 shares Expires 2036-06-05 F3 · derivative.exercise_date: Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 5, 2026. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant. Read SEC document |
| June 05, 2026 Filed Jun 9, 2026 23:42 UTC |
Zimmermann MartineDirector
|
Tax withholdingCommon Stock | 182 | $237.00 | $43,134.00 |
DisclosureSEC source: 0002001011-26-000101 · edgardoc.xml · nonDerivative · entry 2 Zimmermann Martine · CIK 0001994049 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,097 F2 · shares: Represents shares withheld by the Issuer in payment of the tax liability arising in connection with the settlement of restricted stock units. Read SEC document |
| June 05, 2026 Filed Jun 9, 2026 23:42 UTC |
Zimmermann MartineDirector
|
GrantCommon Stock | 836 | $0.00 | $0.00 |
DisclosureSEC source: 0002001011-26-000101 · edgardoc.xml · nonDerivative · entry 1 Zimmermann Martine · CIK 0001994049 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,279 F1 · shares: Represents restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 5, 2026. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant. Read SEC document |
| June 05, 2026 Filed Jun 9, 2026 23:41 UTC |
Sabba Stephen LDirector
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 2,938 | $0.00 Strike: $237.00 | $0.00 |
DisclosureSEC source: 0002001011-26-000100 · edgardoc.xml · derivative · entry 2 Sabba Stephen L · CIK 0001442372 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,938 Underlying: Common Stock · 2,938 shares Expires 2036-06-05 F2 · derivative.exercise_date: Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 5, 2026. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant. Read SEC document |
| June 05, 2026 Filed Jun 9, 2026 23:41 UTC |
Sabba Stephen LDirector
|
GrantCommon Stock | 836 | $0.00 | $0.00 |
DisclosureSEC source: 0002001011-26-000100 · edgardoc.xml · nonDerivative · entry 1 Sabba Stephen L · CIK 0001442372 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,629 F1 · shares: Represents restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 5, 2026. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant. Read SEC document |
| June 05, 2026 Filed Jun 9, 2026 23:41 UTC |
LAMATTINA JOHN LDirector
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 2,938 | $0.00 Strike: $237.00 | $0.00 |
DisclosureSEC source: 0002001011-26-000099 · edgardoc.xml · derivative · entry 2 LAMATTINA JOHN L · CIK 0001216074 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,938 Underlying: Common Stock · 2,938 shares Expires 2036-06-05 F2 · derivative.exercise_date: Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 5, 2026. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant. Read SEC document |
| June 05, 2026 Filed Jun 9, 2026 23:41 UTC |
LAMATTINA JOHN LDirector
|
GrantCommon Stock | 836 | $0.00 | $0.00 |
DisclosureSEC source: 0002001011-26-000099 · edgardoc.xml · nonDerivative · entry 1 LAMATTINA JOHN L · CIK 0001216074 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,560 F1 · shares: Represents restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 5, 2026. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant. Read SEC document |
| June 05, 2026 Filed Jun 9, 2026 23:40 UTC |
KOZARICH JOHN WDirector
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 2,938 | $0.00 Strike: $237.00 | $0.00 |
DisclosureSEC source: 0002001011-26-000098 · edgardoc.xml · derivative · entry 2 KOZARICH JOHN W · CIK 0001223000 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,938 Underlying: Common Stock · 2,938 shares Expires 2036-06-05 F2 · derivative.exercise_date: Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 5, 2026. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant. Read SEC document |
| June 05, 2026 Filed Jun 9, 2026 23:40 UTC |
KOZARICH JOHN WDirector
|
GrantCommon Stock | 836 | $0.00 | $0.00 |
DisclosureSEC source: 0002001011-26-000098 · edgardoc.xml · nonDerivative · entry 1 KOZARICH JOHN W · CIK 0001223000 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,622 F1 · shares: Represents restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 5, 2026. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant. Read SEC document |
| June 05, 2026 Filed Jun 9, 2026 23:35 UTC |
Haas JasonDirector
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 2,938 | $0.00 Strike: $237.00 | $0.00 |
DisclosureSEC source: 0002001011-26-000097 · edgardoc.xml · derivative · entry 2 Haas Jason · CIK 0001883821 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,938 Underlying: Common Stock · 2,938 shares Expires 2036-06-05 F2 · derivative.exercise_date: Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 5, 2026. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant. Read SEC document |
| June 05, 2026 Filed Jun 9, 2026 23:35 UTC |
Haas JasonDirector
|
GrantCommon Stock | 836 | $0.00 | $0.00 |
DisclosureSEC source: 0002001011-26-000097 · edgardoc.xml · nonDerivative · entry 1 Haas Jason · CIK 0001883821 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,442 F1 · shares: Represents restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 5, 2026. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant. Read SEC document |
| June 05, 2026 Filed Jun 9, 2026 23:35 UTC |
Gray Nancy RyanDirector
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 2,938 | $0.00 Strike: $237.00 | $0.00 |
DisclosureSEC source: 0002001011-26-000096 · edgardoc.xml · derivative · entry 2 Gray Nancy Ryan · CIK 0001714949 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,938 Underlying: Common Stock · 2,938 shares Expires 2036-06-05 F2 · derivative.exercise_date: Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 5, 2026. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant. Read SEC document |
| June 05, 2026 Filed Jun 9, 2026 23:35 UTC |
Gray Nancy RyanDirector
|
GrantCommon Stock | 836 | $0.00 | $0.00 |
DisclosureSEC source: 0002001011-26-000096 · edgardoc.xml · nonDerivative · entry 1 Gray Nancy Ryan · CIK 0001714949 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,930 F1 · shares: Represents restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 5, 2026. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant. Read SEC document |
| June 05, 2026 Filed Jun 12, 2026 21:27 UTC |
Aryeh JasonDirector
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 2,938 | $0.00 Strike: $237.00 | $0.00 |
DisclosureSEC source: 0002001011-26-000103 · edgardoc.xml · derivative · entry 5 Aryeh Jason · CIK 0001376960 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,938 Underlying: Common Stock · 2,938 shares Expires 2036-06-05 F4 · derivative.exercise_date: Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 5, 2026. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant. Read SEC document |
| June 05, 2026 Filed Jun 12, 2026 21:27 UTC |
Aryeh JasonDirector
|
GrantCommon Stock | 836 | $0.00 | $0.00 |
DisclosureSEC source: 0002001011-26-000103 · edgardoc.xml · nonDerivative · entry 1 Aryeh Jason · CIK 0001376960 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 107,580 F1 · shares: Represents restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 5, 2026. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant. F2 · balance_after: The total number of shares owned has been reduced by 7,825 shares to reflect a reallocation of the reporting person's shares in accordance with his account records. Read SEC document |
| June 01, 2026 Filed Jun 2, 2026 22:22 UTC |
Reardon AndrewCLO & Secretary
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $52.27 | $0.00 |
DisclosureSEC source: 0002001011-26-000083 · edgardoc.xml · derivative · entry 9 Reardon Andrew · CIK 0001950232 · CLO & Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 39,444 Underlying: Common Stock · 5,000 shares Expires 2032-08-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The transactions reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on November 24, 2025, in accordance with Rule 10b5-1. F8 · derivative.exercise_date: The stock option vests and is exercisable as to 12.5% of the underlying shares on February 1, 2023, and in 42 substantially equal monthly installments thereafter. Read SEC document |
| June 01, 2026 Filed Jun 2, 2026 22:22 UTC |
Reardon AndrewCLO & Secretary
|
SaleCommon Stock | 200 | $230.41 | $46,082.00 |
DisclosureSEC source: 0002001011-26-000083 · edgardoc.xml · nonDerivative · entry 8 Reardon Andrew · CIK 0001950232 · CLO & Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 41,382 F1 · shares: The transactions reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on November 24, 2025, in accordance with Rule 10b5-1. Read SEC document |
| June 01, 2026 Filed Jun 2, 2026 22:22 UTC |
Reardon AndrewCLO & Secretary
|
SaleCommon Stock | 1,216 | $229.47 | $279,032.60 |
DisclosureSEC source: 0002001011-26-000083 · edgardoc.xml · nonDerivative · entry 7 Reardon Andrew · CIK 0001950232 · CLO & Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 41,582 F1 · shares: The transactions reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on November 24, 2025, in accordance with Rule 10b5-1. F7 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $229.0900 to $230.0000. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 01, 2026 Filed Jun 2, 2026 22:22 UTC |
Reardon AndrewCLO & Secretary
|
SaleCommon Stock | 584 | $228.57 | $133,487.10 |
DisclosureSEC source: 0002001011-26-000083 · edgardoc.xml · nonDerivative · entry 6 Reardon Andrew · CIK 0001950232 · CLO & Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 42,798 F1 · shares: The transactions reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on November 24, 2025, in accordance with Rule 10b5-1. F6 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $228.0500 to $228.9650. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 01, 2026 Filed Jun 2, 2026 22:22 UTC |
Reardon AndrewCLO & Secretary
|
SaleCommon Stock | 400 | $226.78 | $90,711.76 |
DisclosureSEC source: 0002001011-26-000083 · edgardoc.xml · nonDerivative · entry 5 Reardon Andrew · CIK 0001950232 · CLO & Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 43,382 F1 · shares: The transactions reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on November 24, 2025, in accordance with Rule 10b5-1. F5 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $226.5250 to $227.0100. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 01, 2026 Filed Jun 2, 2026 22:22 UTC |
Reardon AndrewCLO & Secretary
|
SaleCommon Stock | 1,432 | $225.97 | $323,585.03 |
DisclosureSEC source: 0002001011-26-000083 · edgardoc.xml · nonDerivative · entry 4 Reardon Andrew · CIK 0001950232 · CLO & Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 43,782 F1 · shares: The transactions reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on November 24, 2025, in accordance with Rule 10b5-1. F4 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $225.5200 to $226.3700. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 01, 2026 Filed Jun 2, 2026 22:22 UTC |
Reardon AndrewCLO & Secretary
|
SaleCommon Stock | 677 | $225.20 | $152,459.25 |
DisclosureSEC source: 0002001011-26-000083 · edgardoc.xml · nonDerivative · entry 3 Reardon Andrew · CIK 0001950232 · CLO & Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 45,214 F1 · shares: The transactions reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on November 24, 2025, in accordance with Rule 10b5-1. F3 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $224.5100 to $225.4600. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 01, 2026 Filed Jun 2, 2026 22:22 UTC |
Reardon AndrewCLO & Secretary
|
SaleCommon Stock | 491 | $223.95 | $109,957.83 |
DisclosureSEC source: 0002001011-26-000083 · edgardoc.xml · nonDerivative · entry 2 Reardon Andrew · CIK 0001950232 · CLO & Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 45,891 F1 · shares: The transactions reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on November 24, 2025, in accordance with Rule 10b5-1. F2 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $223.4250 to $224.3800. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 01, 2026 Filed Jun 2, 2026 22:22 UTC |
Reardon AndrewCLO & Secretary
|
Exercise / conversionCommon Stock | 5,000 | $52.27 | $261,350.00 |
DisclosureSEC source: 0002001011-26-000083 · edgardoc.xml · nonDerivative · entry 1 Reardon Andrew · CIK 0001950232 · CLO & Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 46,382 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The transactions reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on November 24, 2025, in accordance with Rule 10b5-1. Read SEC document |
| May 27, 2026 Filed May 28, 2026 23:43 UTC |
Espinoza OctavioChief Financial Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 764 | $0.00 Strike: $63.62 | $0.00 |
DisclosureSEC source: 0002001011-26-000071 · edgardoc.xml · derivative · entry 4 Espinoza Octavio · CIK 0001905248 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,407 Underlying: Common Stock · 764 shares Expires 2032-12-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Grant to reporting person of stock options that will vest and become exercisable over a 4-year period measured from December 5, 2022, with 12-1/2% of the shares subject to the stock options vesting on the date that is six months after December 5, 2022 and the remaining stock options vesting in 42 equal monthly installments thereafter. Read SEC document |
| May 27, 2026 Filed May 28, 2026 23:43 UTC |
Espinoza OctavioChief Financial Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 972 | $0.00 Strike: $52.84 | $0.00 |
DisclosureSEC source: 0002001011-26-000071 · edgardoc.xml · derivative · entry 3 Espinoza Octavio · CIK 0001905248 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 972 shares Expires 2032-05-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock option vests as to approximately 55% of the underlying shares in 12 substantially equal monthly installments beginning on January 5, 2025, and approximately 45% of the underlying shares in two substantially equal monthly installments thereafter. Read SEC document |
| May 27, 2026 Filed May 28, 2026 23:43 UTC |
Espinoza OctavioChief Financial Officer
|
Exercise / conversionCommon Stock | 972 | $52.84 | $51,360.48 |
DisclosureSEC source: 0002001011-26-000071 · edgardoc.xml · nonDerivative · entry 2 Espinoza Octavio · CIK 0001905248 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,679 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 27, 2026 Filed May 28, 2026 23:43 UTC |
Espinoza OctavioChief Financial Officer
|
Exercise / conversionCommon Stock | 764 | $63.62 | $48,605.68 |
DisclosureSEC source: 0002001011-26-000071 · edgardoc.xml · nonDerivative · entry 1 Espinoza Octavio · CIK 0001905248 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,707 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 13, 2026 Filed May 15, 2026 01:08 UTC |
KOZARICH JOHN WDirector
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 1,575 | $0.00 Strike: $69.51 | $0.00 |
DisclosureSEC source: 0002001011-26-000049 · edgardoc.xml · derivative · entry 11 KOZARICH JOHN W · CIK 0001223000 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,575 shares Expires 2026-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: This Option was previously reported as a Grant of 2,329 shares, which vested in full on May 23, 2017, at an exercise price of $119.3000 per share but was adjusted pursuant to the OmniAb Inc. separation from the issuer. Read SEC document |
| May 13, 2026 Filed May 15, 2026 01:08 UTC |
KOZARICH JOHN WDirector
|
SaleCommon Stock | 1,575 | $223.50 | $352,012.50 |
DisclosureSEC source: 0002001011-26-000049 · edgardoc.xml · nonDerivative · entry 9 KOZARICH JOHN W · CIK 0001223000 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 41,786 Read SEC document |
| May 13, 2026 Filed May 15, 2026 01:08 UTC |
KOZARICH JOHN WDirector
|
Exercise / conversionCommon Stock | 1,575 | $69.51 | $109,478.25 |
DisclosureSEC source: 0002001011-26-000049 · edgardoc.xml · nonDerivative · entry 8 KOZARICH JOHN W · CIK 0001223000 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 43,361 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.